Results 211 to 220 of about 229,722 (383)

PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3‐L1 adipocytes

British Journal of Pharmacology, EarlyView.
Basal conditions: •Ins/PDE3B lowers cytoplasmic cAMP (cyt‐cAMP) without affecting plasma membrane cAMP (pm‐cAMP). •Insulin decreases lipid droplet cAMP (LD‐cAMP) independent of PDE3B. •FGF1/PDE4D modestly reduces both cyt‐ and pm‐cAMP, while PDE4D alone can modulate LD‐cAMP. ISO stimulation: •Ins/PDE3B has minimal impact on cyt‐cAMP.
Johannes Krier, David Spähn, David Arturo Juarez Lopez, Judith L. Nono, Judith Seigner, Lisa Jacob, Siegfried Ussar, Robert Lukowski, Andreas L. Birkenfeld, Gencer Sancar   +9 more
wiley   +1 more source

Covalent Binding of the Boronic Acid-Based Inhibitor GSK4394835A to Phosphodiesterase 3B, a Drug Target for Cardiovascular Disease. [PDF]

J Med Chem
Eaton SA, Christianson DW.
europepmc   +1 more source

Phosphodiesterase 4D Gene, Ischemic Stroke, and Asymptomatic Carotid Atherosclerosis [PDF]

, 2005
Steve Bevan, L. Porteous, Matthias Sitzer, Hugh S. Markus   +3 more
openalex   +1 more source

Corrigendum: Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2

, 2023
Mark Thursz, Fouzia Sadiq, Julia A. Tree, Peter Karayiannis, David W. C. Beasley, Wanwissa Dejnirattisai, Juthathip Mongkolsapaya, Gavin Screaton, Matthew E. Wand, Michael J. Elmore, Miles W. Carroll, Ian Matthews, Howard Thomas   +12 more
openalex   +1 more source

An intracellular recombinant single‐chain variable antibody fragment as a new class of phosphodiesterase type 5 inhibitors

British Journal of Pharmacology, EarlyView.
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz, Sophie Sprenger, Olga Schweigert, Sanika Mohagaonkar, Matti Walsdorff, Tanja Zeller, Filip Berisha, Viacheslav O. Nikolaev, Sergei D. Rybalkin   +8 more
wiley   +1 more source

The diguanylate cyclase and phosphodiesterase locally regulate the virulence factors in Vibrio vulnificus. [PDF]

Gut Pathog
Yang JR, Chen KT, Chen YW, Lai SJ.
europepmc   +1 more source

Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A

, 1999
Scott H. Soderling, Sharon J. Bayuga, Joseph A. Beavo   +2 more
openalex   +2 more sources

Differential segment‐specific signalling pathways for guanylate cyclase C‐activated anion secretion in murine ileocolon

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Guanylate cyclase‐C (GC‐C) is the receptor for endogenous (uro)guanylin peptides, bacterial toxins and pharmacological analogues. Receptor activation leads to intestinal fluid loss, but also activates an antiproliferative pathway and is a promising target in colorectal cancer therapy.
Renjie Xiu, Johannes Reiner, Franz Hofmann, Azam Salari, Ursula Seidler   +4 more
wiley   +1 more source

Development and assessment of a peptide vaccine against ovarian cancer utilizing nanoliposomes loaded with P53, WT1, and CA125 epitopes. [PDF]

J Ovarian Res
Shariati F, Hashemi M, Peyvandi M, Jebali A, Entezari M.   +4 more
europepmc   +1 more source

Identification of c-di-GMP Derivatives Resistant to an EAL Domain Phosphodiesterase

, 2012
Carly A. Shanahan, Barbara L. Gaffney, Roger A. Jones, Scott A. Strobel   +3 more
openalex   +2 more sources